ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has acquired Firecrest Clinical Ltd, a market leading provider of technology solutions that boost investigator site performance and study management, for an undisclosed consideration.
Founded in 2001 and headquartered in Limerick, Ireland, Firecrest Clinical provides a comprehensive site performance management system that has been used by nine of the world’s top-10 pharma companies to improve compliance, consistency and execution of activities at investigative sites. The web-based solution enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to sites.
“We are delighted to be joining ICON at a time when technology is driving transformation within the pharmaceutical and clinical trials industry,” commented Gary Hughes, Firecrest CEO and co-founder. “Leveraging ICON’s global presence and deep client relationships will enable us to continue to grow and develop new and innovative technology solutions. We also see real synergies between both companies in terms of technology vision and look forward to combining the expertise from both companies to drive innovation.”
“Delivering consistent, real-time information to sites and a clear path to follow in the conduct of trials not only boosts the quality of trials, it also drives efficiencies and improves study timelines,” commented Peter Gray, CEO at ICON plc. “We have worked with Firecrest on a number of trials and have seen first hand how their technology improves quality through enhanced protocol compliance and drives efficiencies by reducing data queries and errors at sites. Our combined commitment to quality and our shared vision for using innovative technology to deliver more efficient and effective development programs make the companies a good fit.”
Oaklins' team in Ireland acted as the exclusive financial advisor to Firecrest Clinical´s shareholders in the sale of the company to ICON plc.
© 2019 Oaklins. Tous les droits sont réservés. Oaklins est l'appellation commerciale collective de sociétés membres indépendantes affiliées à Oaklins International Inc. Pour plus d'informations sur la nature de l'affiliation, consultez le site Web www.oaklins.com/legal.